Turning Point Therapeutics, Inc.

Home » Turning Point Therapeutics, Inc.

IPO

Turning Point Therapeutics, Inc.

We are a clinical-stage biopharmaceutical company designing and developing novel small molecule, targeted oncology therapies to address key limitations of existing therapies and improve the lives of patients.

Symbol

TPTX

Price Range
$16.00 - $18.00

Final Shares
8,800,000

Effective Date
April 18, 2019

Underwriters
GOLDMAN SACHS & CO. LLC

To view the prospectus for Turning Point Therapeutics, Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253